Sign in Subscribe

Alex Chompff

Rare neurological syndrome as first sign of colon cancer in 43-year-old

Skip to content The CRC Digest Rare neurological syndrome as first sign of colon cancer in 43-year-old A 43-year-old man with progressive sensory neuropathy was diagnosed with Stage IIIA colon adenocarcinoma after anti-Hu antibodies led to discovery of an ascending colon mass; the patient had not undergone recommended early screening

CRC Research Finding

Skip to content The CRC Digest ▸ Multi-omics deep learning model predicts anti-EGFR therapy response in liver metastases A multi-center study developed a deep learning framework integrating multi-omics data to predict which RAS wild-type colorectal cancer liver metastases patients will benefit from cetuximab therapy, addressing primary resistance challenges. (Curr Cancer Drug

CRC Research Update — June 30, 2026

Today's colorectal cancer research highlights

CRC Research Finding

Skip to content The CRC Digest ◇ MMR Protein Expression Patterns Vary by Patient Characteristics A study of 80 Chinese CRC patients examined how deficient mismatch repair status relates to clinical features, providing insights into this key molecular subtype that affects immunotherapy response. (Front Med) This content is informational only and

CRC Research Update — June 29, 2026

Today's colorectal cancer research highlights

Patient-Reported Outcomes After Treatment

Skip to content The CRC Digest Patient-Reported Outcomes After Treatment Real-world study found older patients reported better functional outcomes, with age showing selective effects on quality of life measures. This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC

AI Detection in Surveillance Colonoscopy

Skip to content The CRC Digest AI Detection in Surveillance Colonoscopy Computer-aided detection increased adenoma detection in 5,309 patients undergoing post-polypectomy surveillance. This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC Digest — crcdigest.com

ColoSense RNA-Based At-Home Test

Skip to content The CRC Digest ColoSense RNA-Based At-Home Test First FDA-approved RNA-based at-home screening test now available nationwide through Labcorp. This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC Digest — crcdigest.com

CRC Research Finding

Skip to content The CRC Digest ♥ Real-World Study Identifies What Matters Most to Patients After CRC Treatment A pragmatic observational study using patient-reported outcome measures (PROMs) following colorectal cancer treatment found that older patients reported better overall functional outcomes, while tumour site did not influence functional or symptom scores. (ANZ

CRC Research Update — June 28, 2026

Today's colorectal cancer research highlights